observed with CHO cells that extracellular Glu levels did not change upon disruption of BCAT1/2 expression [17], which was not anticipated based on the reduced Glu release demonstrated in glioma cells upon BCAT1 suppression [18]. This evidence concerns the gene BCAT1 and central nervous system cancer.